tm logo

Monitor this mark

View On USPTO

MTELIQ
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 28 Aug 2024

Last Applicant/ Owned by

Geron Corporation

919 E. Hillsdale Blvd., Suite 250

Foster City

CA

94404

Serial Number

97595380 filed on 16th Sep 2022

Registration Number

N/A

Correspondent Address

Sharon R. Smith

Sharon R. Smith Goodwin Procter LLP

San Francisco, CA 94111

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

MTELIQ

pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancer, and diseases, disorders and conditions of the hematological systems

Classification Information

Class [005]
Pharmaceutical Products

pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancer, and diseases, disorders and conditions of the hematological systems

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97595380

Mark Type

No Service/Collective Mark

Attorney Docket Number

No GER-605

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
28th Aug 2024SOU EXTENSION 2 FILED
28th Aug 2024SOU EXTENSION 2 GRANTED
28th Aug 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28th Aug 2024SOU TEAS EXTENSION RECEIVED
22nd Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21st Feb 2024SOU EXTENSION 1 GRANTED
21st Feb 2024SOU TEAS EXTENSION RECEIVED
21st Feb 2024SOU EXTENSION 1 FILED
26th Sep 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01st Aug 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED